08/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/2023

Aug 30, 2023, 17:45 | Blog
Judith Rose: Yesterday Richard T. Lee and I hosted our first Department of Supportive Care Medicine OC retreat and it was a blast!
In a post by Judith Rose, the Director of Supportive and Integrative Care Programs at…
Aug 30, 2023, 17:44 | Opinion
Naveen Pemmaraju: Wonderful gathering of thought leaders, friends, colleagues in our myeloid leukemia field this weekend at the International Workshop on Acute Leukemias 2023 in San Diego!
Aug 30, 2023, 17:43 | Insight
Arya Roy: Our new article: Oncotype Dx score and HER2- low expression in breast cancer published in Cancers MDPI!
In a post by Arya Roy, Hematology-Oncology Fellow at the Roswell Park Comprehensive Cancer Center,…
Aug 30, 2023, 17:42 | Opinion
Emma B. Holliday: Is it lame to want what you already have?
Quoting Emma B. Holliday, a Radiation oncologist at the University of Texas MD Anderson Cancer…
Aug 29, 2023, 21:37 | Insight
Bishal Gyawali: Congratulations to Dr. Abhenil Mittal and our Queen's University Department of Oncology resident Dr. Kristin Wright on the publication of this important paper.
Aug 29, 2023, 21:26 | Insight
Ishwaria Subbiah: Nearly 1 in 3 physicians with the HIGHEST possible resilience score still had burnout!
Ishwaria Subbiah, the Executive Director of Cancer Care Equity and Professional Wellness at Sarah Cannon…
Aug 29, 2023, 20:46 | Blog
Sylvester is building on its Cancer Research initiatives as it received $1.5 million to accelerate cancer data and bioinformatics resources. - Sylvester Comprehensive Cancer Center
Aug 29, 2023, 19:15 | Insight
Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Andres Gomez, an Associate Professor at Universidad Autónoma de Nuevo León, Mexico, recently tweeted: "Venetoclax…
Aug 29, 2023, 19:14 | Stories
Cynthia Jordan: Met Bec’s from Australia with Stage 2 Lobular Carcinoma Breast Cancer.
Cynthia Jordan, the Founder and CEO at Learn Look Locate, recently posted on LinkedIn: "Met…
Aug 29, 2023, 19:13 | Insight
Rafael Fonseca: Some musings on myeloma therapy after coming back from ASCO and EHA 2023.
Rafael Fonseca, the Chief Innovation Officer at Mayo Clinic, Arizona, recently tweeted: "Some musings on…
All: 539 Posts: 31 - 40